Coverage
-
December 23, 2015
Litigation over generic Paxil sales ended Tuesday, when the embroiled drugmakers quietly agreed to drop the New Jersey federal suit accusing GlaxoSmithKline LLC of breaching an exclusivity agreement with Mylan by allowing Apotex to sell generics of the antidepressant in resolving an antitrust dispute.
3 other articles on this case.
View all »